# Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke

Study · id `cardio:ct-nct05128513` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05128513](<https://clinicaltrials.gov/study/NCT05128513>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05128513

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 356 participants.

## Technical summary

Registry record NCT05128513. Randomized; single masking; primary purpose treatment. Start 2022-01-14 (actual); primary completion 2027-04-08 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 356 participants (planned count; ClinicalTrials.gov record NCT05128513, source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)
- Started: 2022-01-14 (actual) (ClinicalTrials.gov record NCT05128513, source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)
- Primary completion: 2027-04-08 (anticipated) (ClinicalTrials.gov record NCT05128513, source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)
- Completion: 2027-04-08 (anticipated) (ClinicalTrials.gov record NCT05128513, source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT05128513, source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "SUSPENDED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05128513-2026-04-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke
- Condition: Hemorrhagic Stroke
- Intervention (Device): DELP
- Lead sponsor: General Hospital of Shenyang Military Region
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)

## Provenance

Content hash: 306b75edbdc450f574935bd9adc469666c206da276b44839b8ae1db601a9ced6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
